NanoViricides
NNVC
#10057
Rank
โ‚น2.53 B
Marketcap
โ‚น117.38
Share price
4.88%
Change (1 day)
-6.61%
Change (1 year)

NanoViricides (NNVC) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น0.76 Billion

According to NanoViricides's latest financial reports the company's total assets are โ‚น0.76 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

NanoViricides - Total assets on balance sheet (from 2006 to 2025)

Total assets by year

Year Total assets Change
2024-06-30โ‚น1.06 B-22.92%
2023-06-30โ‚น1.38 B-25.25%
2022-06-30โ‚น1.85 B-17.57%
2021-06-30โ‚น2.25 B24.24%
2020-06-30โ‚น1.81 B95.39%
2019-06-30โ‚น0.92 B-26.96%
2018-06-30โ‚น1.26 B-27.25%
2017-06-30โ‚น1.74 B-29.44%
2016-06-30โ‚น2.47 B-12%
2015-06-30โ‚น2.80 B6.83%
2014-06-30โ‚น2.63 B169.31%
2013-06-30โ‚น0.97 B12.57%
2012-06-30โ‚น0.86 B80.86%
2011-06-30โ‚น0.47 B14.95%
2010-06-30โ‚น0.41 B190.59%
2009-06-30โ‚น0.14 B127.9%
2008-06-30โ‚น63.01 M15.15%
2007-06-30โ‚น54.72 M-56.73%
2006-06-30โ‚น0.12 B
2005-06-30N/A

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
BioCryst Pharmaceuticals
BCRX
โ‚น40.61 B 5,241.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น107.35 B 14,018.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น5.325 T 700,300.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น8.815 T 1,159,264.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น11.787 T 1,550,034.74%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น7.502 T 986,613.06%๐Ÿ‡ฌ๐Ÿ‡ง UK